|
ZNF419 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.982300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.401700E-04 |
| Normal-vs-Stage2 |
6.762200E-02 |
| Normal-vs-Stage3 |
9.788300E-04 |
| Normal-vs-Stage4 |
6.502000E-02 |
| Stage1-vs-Stage2 |
3.913600E-01 |
| Stage1-vs-Stage3 |
3.541600E-01 |
| Stage1-vs-Stage4 |
6.706200E-01 |
| Stage2-vs-Stage3 |
1.950250E-01 |
| Stage2-vs-Stage4 |
8.298600E-01 |
| Stage3-vs-Stage4 |
3.295200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.035900E-04 |
| Normal-vs-AfricanAmerican |
1.761160E-01 |
| Normal-vs-Asian |
7.061700E-02 |
| Caucasian-vs-AfricanAmerican |
3.430800E-01 |
| Caucasian-vs-Asian |
3.752000E-01 |
| AfricanAmerican-vs-Asian |
8.105000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.354300E-02 |
| Normal-vs-Female |
2.182700E-04 |
| Male-vs-Female |
1.823410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.018200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.917600E-03 |
| Normal-vs-Age(61-80Yrs) |
8.679400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.626800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.272600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.389200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.070000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.909400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.896200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.657800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.51180000000407E-05 |
| Classical-VS-Follicular |
4.316600E-01 |
| Classical-VS-Other |
2.962600E-01 |
| Classical-VS-Normal |
6.235800E-03 |
| Tall-VS-Follicular |
5.921100E-03 |
| Tall-VS-Other |
7.246100E-02 |
| Tall-VS-Normal |
7.14769999965448E-07 |
| Follicular-VS-Other |
8.843600E-02 |
| Follicular-VS-Normal |
8.362200E-03 |
| Other-VS-Normal |
6.091600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.498300E-03 |
| Normal-vs-N1 |
5.574500E-02 |
| N0-vs-N1 |
6.834200E-01 |
|
|
